Randomized, Placebo-Controlled Trial of Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (CTN-0109)
$1,154,351N01FY2021DANIH
The Emmes Company, Llc, Rockville MD
Investigators
Abstract
Randomized, Placebo-Controlled Trial of Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (CTN-0109)
View original record on NIH RePORTER →